Defining the Market Segment for Ultra-Rare Gene Fusions: Granular Stratification by Cancer Type, Diagnostic Method, and Patient Sub-Population Characteristics
  The market for a rare targeted therapy, such as one addressing the NGR1 fusion, is not a monolithic entity but rather a collection of intricate segments. Effective commercial strategy relies on the precise stratification and targeting of these sub-populations. The most fundamental segmentation is by tumor type; although the NGR1 fusion may occur across multiple cancers (e.g., lung,...
0 Yorumlar 0 hisse senetleri 658 Views 0 önizleme
MTSocial https://mtsocial.ir